No menu items!

    AiM Medical Robotics Raised $3.4M on Seed Financing

    AiM Medical Robotics Logo

    AiM Medical Robotics, a Fort Lauderdale, Fla.-based developer of MRI-compatible intraoperative robotics for neurosurgery, raised $3.4m in seed funding.

    The round was led by IQ Capital and Surrey Capital Partners with participation from The Lambda Fund, a part of the Lamport Family Office, Triple Ring Technologies, and Worcester Polytechnic Institute (WPI), amongst additional inside investors. As of the close, Samantha Surrey, Founder of Surrey Capital Partners, has joined AiM’s Board of Directors.

    The company plans to use the funds for the acceleration of the development of its MRI compatible robotics platform and to continue growing its research, engineering, clinical, and medical affairs team.

    Led by Bob Cathcart, CEO, AiM is advancing the MRI-compatible robotics platform, which is designed to improve outcomes for patients undergoing neurosurgery for functional brain disorders (Parkinson’s, Epilepsy, etc.) AiM will also help hospitals save money by reducing the time and errors they make, as well as preventing cancer. The company will also

    In March 2022, AiM announced that it had appointed Dr. Jonathan Sackier as its Chief Medical Officer (CMO). The news came on the heels of AiM’s announcement that Gregory Cole, Ph.D. had been appointed as its Chief Technology Officer (CTO).

    Get latest news from African Startup ecosystem

    Latest stories

    You might also like...